NIH-funded research NIH-funded research

How immune cells affect heart health and disease

Official title: Macrophages in Cardiovascular Health

Funded at Massachusetts General Hospital · NIH-11011515 · Data updated 2026-11-12

This study is looking at how certain immune cells called macrophages affect heart health and disease, especially when faced with risk factors, to find new ways to improve heart health while keeping your immune system strong.

More Cardiovascular Health research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startFebruary 1, 2025
Project endJanuary 31, 2032
Funding year2025
Award (this year)$1,127,798
NIH project number1R35HL176359-01
Project IDNIH-11011515 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals at risk for cardiovascular diseases, particularly those with inflammation-related conditions.

Less likely to help

Patients with stable cardiovascular health and no risk factors may not benefit from this research.

What this research studies

This research investigates the role of macrophages, a type of immune cell, in cardiovascular health and disease. It aims to understand how these cells influence inflammation and contribute to cardiovascular conditions, particularly in response to risk factors. By utilizing advanced imaging techniques and analyzing cellular changes, the research seeks to identify potential therapeutic targets that could improve heart health without compromising the body's defense mechanisms. The findings could lead to new treatments that harness the body's immune response to combat cardiovascular diseases.

Why it matters

Potential benefit: If successful, this research could lead to innovative therapies that improve cardiovascular health by targeting specific immune responses.

How similar studies have gone: Other research has shown promise in leveraging immune modulation for treating cardiovascular diseases, indicating a potential for success in this approach.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Nahrendorf, Matthias — Massachusetts General Hospital
  • Study coordinator: Nahrendorf, Matthias

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.